Szukaj

Wyniki wyszukiwania

Wyświetla 10 z 21 wyniki

Podczas sesji wrześniowej Parlament ma głosować nad sprawozdaniem przyjętym przez Komisję Ochrony Środowiska Naturalnego, Zdrowia Publicznego i Bezpieczeństwa Żywności w sprawie wniosku dotyczącego przeglądu przepisów UE dotyczących krwi, tkanek i komórek. Wniosek ten oznacza nowy etap budowania silnej europejskiej unii zdrowotnej. Przyjęte w głosowaniu sprawozdanie będzie stanowiskiem Parlamentu w negocjacjach z Radą.

Antimicrobial resistance (the ability of a microorganism to survive in the presence of a medicine designed to inhibit or kill it) is threatening the capacity to prevent and cure infectious diseases. In the European Union, it causes an estimated 35 000 deaths per year, and places an annual financial burden of €1.1 billion on healthcare systems. In 2019, the World Health Organization declared antimicrobial resistance (AMR) to be one of the top 10 global public health threats facing humanity. On 26 ...

Antimicrobial resistance (AMR) is a global, multidimensional phenomenon occurring in humans, animals, and environmental ecosystems. It is the ability of microbes, e.g. bacteria, viruses, fungi and protozoa, to survive in the presence of medicines designed to kill or inactivate them (antimicrobials: antibiotics, antivirals, antifungals and antiprotozoals). At patient level, AMR hampers the effective treatment of microbial infections, leading to prolonged, severe disease and, in some cases, death. ...

Antimicrobial-resistant infections are predicted to become the second biggest cause of death worldwide by 2050. Despite increasing investment in the development of new antimicrobials, awareness campaigns on antimicrobial misuse and abuse, and monitoring of antimicrobial use and resistance in animals, humans and the environment, antimicrobial resistance continues to grow and the last three decades have not seen even one novel antimicrobial class reach the market. Could the answer lie in a 'Trojan ...

This study examines the zoonotic disease risks posed by the livestock sector (including fur production), reviews the risks posed by different livestock species and production systems, and examines case studies of past zoonotic disease epidemics. Building on this evidence, it reviews EU zoonosis surveillance and control arrangements. It recommends improvements including integration of human and animal disease surveillance services, expanded use of syndromic surveillance and changes to the funding ...

Over the last decades, a variety of fatal infectious diseases have had zoonotic origins. The linkages between hosts, vectors, parasites and pathogens can be influenced by a multitude of factors, such as biodiversity, wildlife and land use. High levels of biodiversity may be a potential source of pathogen transmission, but biodiversity loss can also promote transmission by increasing the number of competent hosts for a pathogen. Biodiversity conservation reduces the risk of zoonotic diseases when ...

As 13% of deaths in the EU 28 Member States (EU-28) were attributable to the environment in 2012,1 it is clear that the effects of climate change are having tangible consequences for the European population. Its pace and intensity could thus lead to increasing health risks accross the EU. Globally, temperatures have already risen by 1°C above pre-industrial levels and a temperature increase of more than 2°C would lead to even greater health risks, especially for vulnerable populations such as the ...

Serious threats to health – such as those due to infectious disease outbreaks or environmental factors – do not respect borders. They do, however, require cross-border cooperation and a coordinated response. Decision No 1082/2013/EU is the framework for European Union action on health emergencies. It provides for information exchange, risk assessment and joint procurement, among other mechanisms. The EU-level response is coordinated by the Health Security Committee. The European Centre for Disease ...

In February 2016 a workshop was held on "Communicable Diseases: EU response to HIV, TB and Hepatitis C", hosted by Ms Glenis WILLMOTT and Mr Alojz PETERLE, co-Chairs of the Health Working Group of the ENVI Committee. It included presentations by representatives of European Commission DG Health and Food Safety, the ECDC-European Centre for Disease Prevention and Control, the World Health Organization Regional Office for Europe and civil society representatives. The workshop and this publication were ...

The Zika virus continues to spread, and there is now strong evidence that it is linked to birth defects and neurological complications. Warnings to pregnant women against travel to affected areas have been stepped up. In view of the summer season, the risk of local transmission in Europe now needs careful consideration, as do the strategies to control the mosquito species that are potential vectors of the Zika virus. This 'At a glance' notes updates an earlier edition, of 25 February 2015: PE 577.988 ...